Ibex Investors’s MediciNova MNOV Stock Holding History

Ibex Investors’s Portfolio MNOV Stock Details MNOV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-46,582	Closed	-$371K	–	240
2018 Q2	$371K	Buy	+46,582	New	+$482K	0.21%	143

Other funds holding MNOV

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

EWM

Essex Woodlands Management The Woodlands, Texas $251M AUM 13.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

Ibex Investors's MNOV Position: Q3 2018 in Review

Ibex Investors sold out of MediciNova (MNOV) in Q3 2018, closing a stake of 46,582 shares — an estimated $371K sold.

Ibex Investors first reported a position in MNOV in Q2 2018 and held it in 1 quarter. The position peaked at $371K in Q2 2018. 46 funds tracked by Wall St. Rank hold MNOV as of Q3 2018.

Ibex Investors reported no remaining MediciNova position as of Q3 2018 after selling out during the quarter.
Ibex Investors sold 46,582 MediciNova shares in Q3 2018, an estimated $371K.
Ibex Investors first reported a position in MediciNova in Q2 2018 and held it in 1 quarter.
Ibex Investors's MediciNova position peaked at $371K in Q2 2018.
46 funds tracked by Wall St. Rank held MediciNova as of Q3 2018.

Based on Ibex Investors's 13F filing for Q3 2018, filed 13 Nov 2018.